Nobio Overview
Nobio develops long-term antibacterial and antiviral solutions for medical, dental, and consumer products. The company commercializes its antimicrobial technology both through its own products and through partnerships with industry leaders. Nobios core technology consists of extremely potent particles covered with a high concentration of highly active antimicrobial molecules that kill a wide range of microorganisms (bacteria, viruses, fungi, etc.) on contact. The Nobio particles can be permanently embedded in, or used as a coating on, many products and materials, providing powerful bioprotection for life. In September 2019, the company received FDA approval to market Infinix, its line of antibacterial products for dental fillings. In response to COVID-19, Nobio is also implementing its technology in personal protective equipment (PPE) and surface coatings. Nobio is working with several industry leaders to incorporate its technology into their medical, dental, and consumer products. Nobio also received a grant from the Israeli Innovation Authority for its work on PPE and is involved in discussions with potential partners for commercialization.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Industrial Technologies |
Funding
| Total funding | $4M |
| Last funding | Undisclosed |
| Stage | B |
| Rounds | 4 |
| Investors | 2 |
Team Members
4
Employees: 11-50
Web & Social Links
| Website | www.nobio.com |
Locations
HaMatechet St 8, Kadima Zoran, Israel
Photos & Videos
3 item(s)
Nobio Business
Sector
Industrial TechnologiesMaterial Innovations & ApplicationsTarget Customer
Healthcare & Life SciencesHealthcareProvidersLaboratoriesIndustrial ManufacturingManufacturing FacilitiesCore Technology
BiologicalsMoleculesTags (17)
bioconvergencedentistspharmaceuticalsnanotechnologymedical-devicesdentalbiotechnologymaterialsmedical-equipmentmicrobiologypackaging-and-containerstextilemanufacturing-facilitieshygienesurface-and-coatingshvachospitalsGeographic Markets
GlobalNobio Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
Nobio Lifecycle
Cumulative Funding Raised Over Time
All Events
Nobio News
7 articlesNobio Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 28 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 12 classification IDs that could be used for matching.
Nobio Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 515281285 |
| Crunchbase | nobio |
| Phone | +97297893000 |
| Creator | Jenny Sotnik-Talisman |
| Creator email | genys30@yahoo.com |
| Last updater | Maor Perlov |
| Updater email | maor.perlov@sncentral.org |
| Last update | 2022-10-06T00:00:00.000Z |
| Created | 2017-12-25T00:00:00.000Z |